Se-Ho Kim

Se-Ho Kim has a strong background in R&D work, with a focus on green and sustainable technologies for API process research and development. Prior to their current position, Se-Ho worked at Orthobond Corporation as a Senior Scientist, where Se-Ho specialized in surface engineering of medical devices with antibacterial and antifouling properties. Se-Ho also held a position at Myrexis, Inc. as a Scientist II, conducting small molecule drug discovery research in various therapeutic areas, particularly oncology. During their time as a Postdoctoral Fellow at the University of Pittsburgh, Se-Ho developed a new strategy for tetrahydroisoquinoline alkaloids using transition metal-catalyzed cyclization.